What Fed. Circ. False Ad Ruling Means For Section 337 Claims
In its long-awaited decision in Amarin Pharma. v. U.S. International Trade Commission, the U.S. Court of Appeals for the Federal Circuit provided guidance on the U.S. International Trade Commission's discretion to decline...To view the full article, register now.
Already a subscriber? Click here to view full article